Prosecution Insights
Last updated: October 25, 2026

Augusta University Research Institute Inc.

Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Analysis

Augusta University Research Institute Inc. has 4 pending office actions in the Biotechnology & Pharmaceuticals technology area. The portfolio is spread across 4 distinct art units and 4 distinct examiners. ROBERT ANTHONY SKROBARCZYK III is the busiest examiner, responsible for 1 pending office action.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

3
Total Pending OAs
1
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (67%)
1
Medium (33%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other1 (33%)
§103 only1 (33%)
Multi-statute (no §101)1 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
67% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
33% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SKROBARCZYK III, ROBERT ANTHONY 1 16.7% +16.3%
MARCSISIN, ELLEN JEAN 1 34.6% +49.4%
JOHNSON, CHRISTOPHER LINDSAY 1 48.6% +78.3%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
19036891 METHODS AND SYSTEMS FOR DEEP BRAIN STIMULATION OF THE NUCLEUS BASALIS OF MEYNERT SKROBARCZYK III, ROBERT ANTHONY —
18346483 SYSTEMS AND REAGENTS FOR DETECTION OF FREE MONOCLONAL IMMUNOGLOBULIN LIGHT CHAINS IN BIOLOGICAL SAMPLES MARCSISIN, ELLEN JEAN —

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18245217 COMPOSITIONS AND METHODS FOR INHIBITING TREM-1 JOHNSON, CHRISTOPHER LINDSAY 77d overdue
19036891 METHODS AND SYSTEMS FOR DEEP BRAIN STIMULATION OF THE NUCLEUS BASALIS OF MEYNERT SKROBARCZYK III, ROBERT ANTHONY —
18346483 SYSTEMS AND REAGENTS FOR DETECTION OF FREE MONOCLONAL IMMUNOGLOBULIN LIGHT CHAINS IN BIOLOGICAL SAMPLES MARCSISIN, ELLEN JEAN —

Top Art Units

Art UnitApps
3792 1
1677 1
1691 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19036891 METHODS AND SYSTEMS FOR DEEP BRAIN STIMULATION OF THE NUCLEUS BASALIS OF MEYNERT SKROBARCZYK III, ROBERT ANTHONY 3792 §102§103 Final Rejection — Pending Jan 24, 2025
18346483 SYSTEMS AND REAGENTS FOR DETECTION OF FREE MONOCLONAL IMMUNOGLOBULIN LIGHT CHAINS IN BIOLOGICAL SAMPLES MARCSISIN, ELLEN JEAN 1677 §101§102§103§112 Non-Final OA — Pending Jul 03, 2023
18245217 COMPOSITIONS AND METHODS FOR INHIBITING TREM-1 JOHNSON, CHRISTOPHER LINDSAY 1691 §103 Final Rejection 77d overdue Pending Mar 14, 2023

Managing Augusta University Research Institute Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Augusta University Research Institute Inc. have?

Augusta University Research Institute Inc. has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.

Which USPTO examiner handles the most Augusta University Research Institute Inc. applications?

Robert Anthony Skrobarczyk III has the most, with 1 of Augusta University Research Institute Inc.'s pending office actions.

What technology area are Augusta University Research Institute Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month